New Multiple Sclerosis Study Aims to Improve Personalized Treatment

Xtalks takes a look at a new cutting-edge study by Sutter Health and DNAnexus that’s interested in identifying clinical and genomic components that contribute to the variability of disease onset, progression and response to treatment seen in MS patients, with the ultimate goal of improving patient health.